Logo-jpd
J Parathyr Dis. 2020;8: e11173.
  Abstract View: 644
  PDF Download: 328

Original

Comparing the effect of sevelamer carbonate versus sevelamer hydrochloride on blood level cholesterol, triglyceride and uric acid in patients undergoing maintenance hemodialysis

Milad Almasi ORCID logo, Bahareh Hajisalimi* ORCID logo

1 Internal Medicine Department, Vali-e-Asr Hospital, Zanjan University of Medical Sciences, Zanjan, Iran.
*Corresponding Author: *Corresponding author: Bahareh Hajisalimi, Email: , Email: baharehhajisalimi@yahoo.com

Abstract

Introduction: Hyperlipidemia and hyperuricemia are important complications of renal failure, especially in patients underlying dialysis, therefore, it is important to control these complications with more effective therapies which have lower side effects and costs. Sevelamer is an agent that binds to bile acids and impairs fat absorption and also reduces the absorption of fat-soluble vitamins.

Objectives: In this study, the effect of sevelamer carbonate and sevelamer hydrochloride was investigated on serum levels of cholesterol, triglyceride and uric acid.

Patients and Methods: In a randomized clinical trial, patients undergoing maintenance hemodialysis who were treated with sevelamer carbonate and sevelamer hydrochloride were enrolled in the study and evaluated for complications and outcomes. After one month, cholesterol, triglyceride and uric acid levels were measured. Data were analyzed at a significance level of less than 0.05 using t-test, ANOVA, Mann-Whitney U and the Kruskal-Wallis tests.

Results: In sevelamer hydrochloride group changes in levels of cholesterol, triglyceride and uric acid were 18.80 ± 28.19 mg/dL, 25.52 ± 73.80 mg/dL and 0.85 ± 2.10 mg/dL, respectively. In sevelamer carbonate group, differences for cholesterol, triglyceride and uric acid were 10.17 ±23.66 mg/dL, 3.84 ± 34.57 mg/dL and 0.60 ± 1.59 mg/dL mg/dL, respectively. Sevelamer hydrochloride reduced serum cholesterol (P = 0.321), triglyceride (P = 0.129) and uric acid (P = 0.679) levels more than sevelamer carbonate, however these differences were not significant.

Conclusion: Due to the better clinical effect of sevelamer hydrochloride, it can be recommended in patients with chronic renal failure with overload of phosphorus accompanied by lipid disorders, especially hypercholesterolemia.

Trial Registration: The trial protocol was approved by the Iranian Registry of Clinical Trial (identifier: IRCT20141016019554N13, https:// en.irct.ir/trial/28916, ethical code; IR.ZUMS.REC.1397.352).


Please cite this paper as: Almasi M, Hajisalimi B. Comparing the effect of sevelamer carbonate versus sevelamer hydrochloride on blood level cholesterol, triglyceride and uric acid in patients undergoing maintenance hemodialysis. J Parathyr Dis. 2020;8:e11173.
First Name
 
Last Name
 
Email Address
 
Comments
 
Security code


Abstract View: 645

Your browser does not support the canvas element.


PDF Download: 328

Your browser does not support the canvas element.

Submitted: 10 May 2020
Accepted: 13 Nov 2020
ePublished: 26 Nov 2020
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - Firefox Plugin)